Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial

Journal of Hospital Infection

Volumn 84, Issue 2, 2013, Pages 159-165

  Selinger, C P ^a   Bell, A ^b   Cairns, A ^c   Lockett, M ^d   Sebastian, S ^e   Haslam, N ^f  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c Wrightington Wigan and Leigh NHS Trust   (United Kingdom)

^d NORTH BRISTOL NHS TRUST   (United Kingdom)

^e HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^f ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Antibiotic associated diarrhoea; Clostridium difficile associated diarrhoea; Probiotics; Prophylaxis; VSL 3

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; VSL3;

ADULT; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG FATALITY; EPISTAXIS; FEMALE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; INTENTION TO TREAT ANALYSIS; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUTH PAIN; MULTICENTER STUDY; NAUSEA; NEOPLASM; PATIENT CODING; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING;

ADULT; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HOSPITALS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROBIOTICS; TREATMENT OUTCOME;

EID: 84878143512     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.02.019     Document Type: Article

References (19)

1. Cremonini F., Di Caro S., Nista E.C., et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002, 16:1461-1467.
2. Kelly C.P., Pothoulakis C., LaMont J.T. Clostridium difficile colitis. NEngl J Med 1994, 330:257-262.
3. Kelly C.P., LaMont J.T. Clostridium difficile infection. Annu Rev Med 1998, 49:375-390.
4. Chandler R.E., Hedberg K., Cieslak P.R. Clostridium difficile-associated disease in Oregon: increasing incidence and hospital-level risk factors. Infect Control Hosp Epidemiol 2007, 28:116-122.
5. Pépin J., Saheb N., Coulombe M.A., et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254-1260.
6. Kuijper E.J., Barbut F., Brazier J.S., et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008, 13(31).
7. Health Protection Agency Clostridium difficile infection: how to deal with the problem 2009, DoH and HPA, London.
8. Herath D., Cranfield J., Henson S. Who consumes functional foods and nutraceuticals in Canada? Results of cluster analysis of the 2006 survey of Canadians' demand for food products supporting health and wellness. Appetite 2008, 51:256-265.
9. Hempel S., Newberry S.J., Maher A.R., et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012, 307:1959-1969.
10. Videlock E.J., Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2012, 35:1355-1369.
11. Plummer S., Weaver M.A., Harris J.C., Dee P., Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 2004, 7:59-62.
12. Hickson M., D'Souza A.L., Muthu N., et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007, 335:80.
13. Health Protection Agency Financial year counts and rates of C. difficile infection by NHS acute Trusts 2011, HPA, London.
14. Dial S., Alrasadi K., Manoukian C., Huang A., Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. Can Med Am J 2004, 171:33-38.
15. Frohmader T.J., Chaboyer W.P., Robertson I.K., Gowardman J. Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial. Am J Crit Care 2010, 19:e1-11.
16. Hickson M. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol 2011, 4:185-197.
17. Pozzoni P., Riva A., Bellatorre A.G., et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2012, 107:922-931.
18. Stone S.P., Fuller C., Savage J., et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ 2012, 344:e3005.
19. Morrow L.E., Kollef M.H., Casale T.B. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010, 182:1058-1064.